LEONARDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.798
AS - Asia 6.844
EU - Europa 3.074
AF - Africa 1.271
SA - Sud America 1.169
OC - Oceania 117
Continente sconosciuto - Info sul continente non disponibili 48
Totale 23.321
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.145
SG - Singapore 2.092
VN - Vietnam 1.164
CN - Cina 1.022
HK - Hong Kong 714
BR - Brasile 682
IT - Italia 451
FI - Finlandia 295
DE - Germania 278
FR - Francia 238
GB - Regno Unito 200
PL - Polonia 197
IN - India 182
BD - Bangladesh 181
UA - Ucraina 125
RU - Federazione Russa 122
IQ - Iraq 115
TR - Turchia 114
AR - Argentina 106
SE - Svezia 95
NL - Olanda 89
JP - Giappone 88
ZA - Sudafrica 80
PH - Filippine 77
PK - Pakistan 72
SA - Arabia Saudita 71
ID - Indonesia 66
EC - Ecuador 63
MX - Messico 63
ES - Italia 58
IE - Irlanda 58
CO - Colombia 56
PY - Paraguay 52
VE - Venezuela 52
CA - Canada 51
CL - Cile 50
MA - Marocco 49
UZ - Uzbekistan 49
AT - Austria 48
MY - Malesia 48
HN - Honduras 47
KG - Kirghizistan 46
EG - Egitto 45
JO - Giordania 44
NP - Nepal 42
CI - Costa d'Avorio 40
KZ - Kazakistan 40
TT - Trinidad e Tobago 40
TZ - Tanzania 40
AZ - Azerbaigian 38
CZ - Repubblica Ceca 38
HR - Croazia 38
LU - Lussemburgo 38
TN - Tunisia 38
BB - Barbados 37
BF - Burkina Faso 37
IL - Israele 37
LV - Lettonia 37
TJ - Tagikistan 37
BA - Bosnia-Erzegovina 36
BG - Bulgaria 36
BS - Bahamas 36
DZ - Algeria 36
IR - Iran 36
KE - Kenya 36
ME - Montenegro 36
PT - Portogallo 36
AU - Australia 35
BJ - Benin 35
MG - Madagascar 35
SI - Slovenia 35
AL - Albania 34
DO - Repubblica Dominicana 34
GR - Grecia 34
RO - Romania 34
CD - Congo 33
HU - Ungheria 33
LA - Repubblica Popolare Democratica del Laos 33
NO - Norvegia 33
TH - Thailandia 33
AO - Angola 32
BE - Belgio 32
EE - Estonia 32
GE - Georgia 32
KR - Corea 32
MK - Macedonia 32
PS - Palestinian Territory 32
TW - Taiwan 32
UY - Uruguay 32
AM - Armenia 31
BY - Bielorussia 31
GH - Ghana 31
HT - Haiti 31
JM - Giamaica 31
MD - Moldavia 31
NI - Nicaragua 31
BO - Bolivia 30
DJ - Gibuti 30
ET - Etiopia 30
IS - Islanda 30
Totale 21.871
Salva come PNG Salva come JPEG
Città #
Singapore 1.296
Ashburn 1.255
San Jose 1.139
Fairfield 1.119
Woodbridge 702
Hong Kong 649
Houston 538
Chandler 503
Ann Arbor 408
Jacksonville 403
Cambridge 399
Seattle 394
Wilmington 387
Ho Chi Minh City 363
Santa Clara 342
Hanoi 313
Beijing 211
Boardman 184
Princeton 182
Los Angeles 152
Helsinki 149
Bytom 135
Lauterbourg 130
San Diego 116
New York 111
Roxbury 91
Munich 83
Padova 74
Medford 72
Da Nang 69
Des Moines 64
Chicago 62
Nanjing 62
São Paulo 62
Council Bluffs 59
Cardiff 54
Tokyo 51
Haiphong 44
Dublin 43
Milan 43
Tashkent 43
Amman 40
Baghdad 40
Buffalo 40
The Dalles 40
Abidjan 38
Bishkek 38
Johannesburg 37
Baku 36
Guangzhou 36
Hefei 36
Warsaw 36
Dushanbe 35
Nassau 35
Bridgetown 34
Vienna 34
Antananarivo 31
Cotonou 31
Vientiane 31
London 30
Lusaka 30
Riga 30
Dakar 29
Jeddah 29
Managua 29
Kampala 28
Libreville 28
Nairobi 28
Orem 28
Ulan Bator 28
Chennai 26
Dar es Salaam 26
Luanda 26
Montevideo 26
Podgorica 26
Tbilisi 26
Accra 25
Addis Ababa 25
Frankfurt am Main 25
Kigali 25
Shanghai 25
Tallinn 25
Yerevan 25
Castries 24
Conakry 24
Lahore 24
Nanchang 24
Niamey 24
Panama City 24
Turku 24
Istanbul 23
Kinshasa 23
Lappeenranta 23
Nouakchott 23
Quito 23
Cairo 22
Djibouti 22
Hải Dương 22
Kuala Lumpur 22
Mumbai 22
Totale 14.245
Salva come PNG Salva come JPEG
Nome #
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma 294
Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis 289
Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops 268
Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type, and are modified by inflammatory stimuli 264
Using helium-generated cold plasma to control infection and healing 258
Effects of Th2 cytochines on expression of collagen, MMP-1 and TIMP-1 in conjunctival fibroblasts 249
Atmospheric-pressure cold plasma induces transcriptional changes in ex vivo human corneas 248
Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in keratoconjunctivitis patients 247
A novel plasma source for sterilization of living tissues 236
Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. 236
Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy 236
Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis. 234
Epidemiology of allergic conjunctivitis: Clinical appearance and treatment patterns in a population-based study 231
Urokinase Plasminogen Activator, uPa Receptor, and Its Inhibitor in Vernal Keratoconjunctivitis 228
Vernal keratoconjunctivitis-like disease in adults 225
Characterisation of the phenotype and function of monocyte-derived dendritic cells in allergic conjunctiva 223
Th1- and Th2-type cytokines in chronic ocular allergy 221
Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of Lodoxamide. 219
Corneal staining patterns in vernal keratoconjunctivitis: The new VKC-CLEK scoring scale 214
Meta-Analysis of Keratoconus Transcriptomic Data Revealed Altered RNA Editing Levels Impacting Keratin Genomic Clusters 213
Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis 211
Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers 209
Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities 208
Microarray-based IgE detection in tears of patients with vernal keratoconjunctivitis 207
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma 206
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression 206
A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study 203
Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. 202
Towards a plasma treatment of corneal infections 201
Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis 198
The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis 197
Profile of Lipid and Protein Autacoids in Diabetic Vitreous Correlates With the Progression of Diabetic Retinopathy 195
Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population. 195
Endoplasmic Reticulum Stress and Unfolded Protein Response in Vernal Keratoconjunctivitis 192
Effects of cyclosporin A on human conjunctival fibroblasts 192
Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments 188
Unusual high exposure to ultraviolet-C radiation 188
Urban eye allergy syndrome: a new clinical entity? 186
Tailored Approach to the Treatment of Vernal Keratoconjunctivitis 186
Corneal confocal microscopy in patients with vernal keratoconjunctivitis 184
Cytokine and chemochine levels in tears and in corneal fibroblast cultures before and after excimer laser treatment 183
Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy. 181
A survey‐based study on diagnosis and management of vernal keratoconjunctivitis 180
Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model 180
Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis 177
Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis. 176
Allergic conjunctivitis: A cross-sectional study 174
Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19 174
Is visual function affected in severe ocular allergies? 173
Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases 172
The First Case of Streptococcus sinensis Endocarditis in Italy: Case Presentation and Systematic Literature Review 171
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. 171
Tracing the SARS-CoV-2 infection on the ocular surface: Overview and preliminary corneoscleral transcriptome sequencing 171
Olopatadine: a drug for allergic conjunctivitis targeting the mast cell 169
Impaired SERPIN–Protease Balance in the Peripheral Lungs of Stable COPD Patients 166
Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans 166
Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. 165
Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease 165
Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine 165
Vernal keratoconjunctivitis: pathogenesis and treatment 162
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: A pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies 161
Ocular Surface Expression of SARS-CoV-2 Receptors 161
Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis 159
A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension 158
Coexistence of neuropathic corneal pain, corneal nerve abnormalities, depression, and low quality of life 156
Detection of severe acute respiratory syndrome coronavirus 2 in corneas from asymptomatic donors 156
Efficacy and comfort of olopatadine vs ketotifen ophthalmic solutions 155
Prevalence of vernal keratoconjunctivitis: a rare disease? 155
Heat shock proteins levels and expression in chronic obstructive pulmonary disease and vernal keratoconjunctivitis 155
Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score 155
Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. 153
Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. 152
Emerging drugs for ocular allergy 151
Office-based ocular procedures for the allergist 150
Managing ocular allergy in the time of COVID-19 150
Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis 149
Ligneous conjunctivitis and use of human plasminogen eyedrops: The Italian experience 148
Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis 148
Cytokines, growth factors and MMPs in tears of vernal keratoconjunctivitis (VKC) patients 148
Characterization of dendritic cell phenotype in allergic conjunctiva: increased expression of Fc epsilon RI, the high-affinity receptor for immunoglobulin E 146
Metagenomic analysis of the conjunctival bacterial and fungal microbiome in vernal keratoconjunctivitis 146
Treatment of Ligneous Conjunctivitis with Plasminogen Eyedrops 145
In vitro effects of fluorochinolone and aminoglycoside antibiotics on human keratocytes 144
Tear eosinophil cationic protein (ECP) in tears of normal subjects and patients affected by vernal keratoconjunctivitis. 143
Allergy and the eye 143
Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis. 143
Allergy and Dry Eye Disease 143
Histaminase activity in vernal keratoconjunctivitis. 142
Allergy and allergic mediators in tears 141
Evidence of epithelial remodelling but not epithelial–mesenchymal transition by transcriptome profiling in vernal keratoconjunctivitis 140
Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro 139
Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics 138
Ocular Surface Expression of SARS-CoV-2 Receptors 138
NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal Keratoconjunctivitis 138
Dry Eye Disease: From Causes to Patient Care and Clinical Collaboration—A Narrative Review 135
Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis 135
Ciclosporin A Cationic Emulsion 0.1% for the Management of Dry Eye Disease: Facts That Matter for Eye-Care Providers 134
In-vivo diagnostic measurements of ocular inflammation 133
Tumor necrosis factor-alpha (TNF-alpha) in seasonal allergic conjunctivitis and vernal keratoconjunctivitis 133
Conjunctival allergen provocation test : guidelines for daily practice 132
Totale 18.079
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.065
article - articoli 63.037
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 291
patent - brevetti 0
selected - selezionate 0
volume - volumi 162
Totale 128.555
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 0 0 0 0 0 157 79
2021/20221.517 35 165 187 88 73 64 116 160 93 29 162 345
2022/20231.007 250 89 60 100 169 96 1 65 104 9 49 15
2023/2024479 19 73 53 43 23 36 16 18 45 10 73 70
2024/20252.962 10 241 139 86 437 63 161 243 223 117 428 814
2025/202612.987 519 1.002 2.013 2.128 1.073 550 1.855 1.191 1.344 762 550 0
Totale 23.494